Page last updated: 2024-10-25

cimetidine and Hemosiderosis

cimetidine has been researched along with Hemosiderosis in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Hemosiderosis: Conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the MONONUCLEAR PHAGOCYTE SYSTEM, without demonstrable tissue damage. The name refers to the presence of stainable iron in the tissue in the form of hemosiderin.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouros, D1
Panagou, P1
Arseniou, P1
Siafakas, NM1

Other Studies

1 other study available for cimetidine and Hemosiderosis

ArticleYear
Idiopathic pulmonary haemosiderosis and autoimmune hypothyroidism: bronchoalveolar lavage findings after cimetidine treatment.
    Respiratory medicine, 1995, Volume: 89, Issue:4

    Topics: Adult; Autoimmune Diseases; Bronchoalveolar Lavage Fluid; Cimetidine; Hemosiderosis; Humans; Hypothy

1995